Interestingly, the highest baseline concentrations of classical biomarkers, such as CSF Tau and Aβ 1-42, in MCI patients have been shown to be strongly associated with subsequent progression to AD (hazard ratio (HR) 17.7, p < 0.0001) [72]. This evidence concerns the gene MAPT and Alzheimer disease.